Expectedly, knockout of BRD9 or I‐BRD9 treatment significantly inhibited glycolytic activities of cells, as indicated by decreased basal ECAR and maximal ECAR in colon cancer cells (Figure 4D,E, Figure S1C). Here, BRD9 is linked to malignant colon neoplasm.